Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
771.12 | -48,81% | -27,8% | 694.320,6 | 0,66% | 2,63% |
|
NYSE:ABBV
AbbVie
|
164.35 | -22,09% | -11,8% | 290.220,37 | 3,79% | 7,03% |
|
LSE:AZN
AstraZeneca PLC
|
121.66 | 18,34% | 40,96% | 188.601,59 | 2,01% | 15,98% |
|
SWX:NOVN
Novartis
|
92.62 | 9,02% | 22,51% | 188.982,44 | 3,54% | 4,67% |
|
SWX:ROG
Roche Holding
|
234.80 | 26,57% | 42,01% | 189.539,61 | 4,22% | 0,43% |
|
NasdaqGS:AMGN
Amgen
|
314.72 | -12,88% | -4,16% | 168.826,73 | 2,82% | 5,31% |
|
NYSE:PFE
Pfizer
|
28.92 | 7,37% | 37,31% | 163.877,87 | 5,83% | -9,31% |
|
ENXTPA:SAN
Sanofi
|
90.24 | 17,91% | 36,66% | 112.810,55 | 4,15% | 8,19% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.11 | 61,44% | 71,76% | 89.415,39 | 5,39% | 13,54% |
|
ENXTBR:UCB
UCB
|
121.50 | -38,88% | -10,63% | 23.054,7 | 1,11% | -2,55% |
|
NYSE:TEVA
Teva Pharmaceutical Industries
|
16.30 | -46,24% | -42,78% | 18.462,04 | 0% | -2,6% |
|
TSE:4503
Astellas Pharma
|
1513.50 | 0% | 0% | 2.713.684,95 | 4,85% | 0% |
|
TSE:4523
Eisai
|
6866.00 | 0% | 0% | 1.968.631,52 | 2,33% | 0% |
|
BIT:REC
Recordati Industria Chimica e Farmaceutica
S.p.A. |
50.80 | 18,28% | 30,99% | 10.363,08 | 2,32% | 10,99% |
|
ENXTPA:IPN
Ipsen
|
121.40 | -14,58% | -6,56% | 9.878,9 | 0,99% | 9,14% |
|
NasdaqGS:ITCI
Intra-Cellular Therapies
|
66.53 | 0% | 0% | 6.858,14 | 0% | 0% |
|
BME:GRF
Grifols
|
9.95 | 239,26% | 342,33% | 5.853,27 | 0% | -19,25% |
|
HLSE:ORNBV
Orion Oyj
|
37.71 | 22,61% | 65,62% | 5.117,58 | 4,31% | -0,43% |
|
NasdaqGS:ALKS
Alkermes
|
24.46 | 179,13% | 204,47% | 4.105,31 | 0% | 18,74% |
|
TSE:4506
Sumitomo Pharma
|
464.00 | 0% | 0% | 396.895 | 0% | 17,88% |
